MESA LABORATORIES INC /CO/

CIK: 7240043 Annual ReportsLatest: 2026-06-03
Revenue: $249,130,000Net Income: $6,712,000Source 10-K
Disclaimer: AI-assisted summary of SEC Form 10-K filings. Not official company content and not investment, legal, accounting, or tax advice. See full disclaimer here.

10-K / June 3, 2026

Revenue:$249,130,000
Income:$6,712,000

10-K / May 28, 2025

Revenue:$241,000,000
Income:-$1,974,000

10-K / June 28, 2024

Revenue:$216,187,000
Income:-$254,246,000

10-K / June 3, 2026

Mesa Laboratories, Inc.

Company and scope

  • Legal name: Mesa Laboratories, Inc., a Colorado corporation
  • Fiscal year end: March 31
  • Headquarters: Lakewood, Colorado
  • Primary business: Global design and manufacture of life sciences tools and critical quality-control solutions for regulated applications in the pharmaceutical, healthcare, and medical device industries
  • Markets and sales:
    • Manufacturing operations in the United States and Europe
    • Products sold by direct sales in North America, Europe, and the Asia Pacific region (APAC), and through independent distributors worldwide
    • Nasdaq ticker: MLAB

Employees (as of March 31, 2026)

  • Total: 717
    • Manufacturing and quality assurance: 347
    • Research and development and engineering: 99
    • Sales and marketing: 179
    • Administrative functions: 92

Business metrics and geography

  • Non-U.S. operations:
    • About 8% of fiscal 2026 sales were from China
    • About 45% of fiscal 2026 sales were from other non-U.S. countries, primarily Europe
  • Backlog (firm orders to be fulfilled within 12 months):
    • March 31, 2026: $33.6 million
    • March 31, 2025: $43.2 million
  • The company realized higher revenues and higher adjusted operating income (a non-GAAP measure) in fiscal 2026 versus the prior year
  • Customer concentration:
    • No single customer accounted for more than 10% of consolidated revenues in fiscal 2026
    • In the Clinical Genomics division, one customer accounted for approximately 20% of that division’s revenues in fiscal 2026

Segments

1) Sterilization and Disinfection Control (SDC)

  • Focus: Biological indicators, chemical indicators, and cleaning indicators for assessing sterilization, decontamination, disinfection, and cleaning processes; sterility assurance testing and laboratory services (primarily dental and pharmaceutical customers)
  • Products and formats:
    • Biological indicators: inoculated carriers (spore strips/discs), self-contained indicators with growth media, process challenge devices (PCDs)
    • Chemical indicators: color-change indicators for sterilization parameter exposure
    • Cleaning indicators: simulants for washer and ultrasonic cleaner performance
    • Growth media and related testing services
  • Manufacturing locations: Bozeman, Montana; Waldems, Germany; Munich, Germany
  • Brands/products produced: GKE Clean-Record indicators, Apex biological indicators, EZTest self-contained indicators, and PCDs
  • Acquisition: GKE GmbH, SAL GmbH, and GKE China were acquired (GKE GmbH/SAL completed October 2023; GKE China completed December 31, 2023) for total consideration of $87.187 million (net of cash and liabilities, including working capital adjustments); $9.555 million was paid in April 2025 to settle the portion held back for indemnification
  • Regulatory: Pursuing 510(k) clearance for certain GKE products in the U.S.

2) Biopharmaceutical Development

  • Focus: Automated systems for protein analysis (immunoassays) and peptide synthesis solutions, plus service and support contracts
  • Capabilities:
    • Protein analysis (immunoassays) to detect and quantify proteins for therapy development and bioprocess workflows
    • Automated peptide synthesis for longer and complex peptides used in therapeutics and research
  • Key products and platforms:
    • Gyrolab xPand and Gyrolab xPlore hardware/software, Gyrolab Bioaffy consumable disks, Gyrolab kits, Rexxip buffers (developed/manufactured in Uppsala, Sweden)
    • PurePep Symphony and Chorus instruments (developed/manufactured in Tucson, Arizona)
  • Production locations: Sweden (products shipped internationally; costs in Swedish krona) and Tucson, Arizona
  • Revenue mix (fiscal 2026):
    • About 35% from consumables (routine purchases)
    • About 40% from hardware purchases (more discretionary)
    • Remainder from service and support agreements
  • Sales channels: Direct sales and independent foreign distributors

3) Calibration Solutions

  • Focus: Quality-control products that use metrology to calibrate critical parameters for renal care, gas/air flow, environmental/process monitoring, and torque testing
  • Product families:
    • Calibration instruments for gas/air flow and environmental/process monitoring (data loggers)
    • Torque-testing systems
    • Renal care meters for dialysis machine calibration and consumable calibration solutions for dialysis clinics
    • Continuous monitoring systems: wireless sensors for temperature, humidity, pressure and differential pressure with cloud or local-server data transmission, alarms, and notifications
  • Manufacturing: Lakewood, Colorado and Hanover, Germany
  • Applications: Quality control and regulatory compliance across pharmaceutical, laboratory, medical device, manufacturing, industrial, and environmental settings

4) Clinical Genomics

  • Focus: High-throughput genetic analysis instruments, consumables, and related services for clinical research labs and CROs
  • Core platform: MassARRAY system (mass spectrometry with end-point PCR) enabling multiplexed genetic analysis
  • Consumables: Chips, panels, and reagent solutions; consumables account for approximately 80% of division revenues (hardware sales are more cyclical)
  • Services: Maintenance contracts and customized laboratory services
  • Production: Instruments and consumables manufactured in San Diego, California
  • Customers and channels: Direct sales and independent distributors; customers include clinical research labs, contract research organizations, specialty/reference/pathology labs, academic, hospital, and government facilities

Other business context

  • Strategy and operating approach: Organic growth, targeted acquisitions, and continuous efficiency improvements through the Mesa Way — a lean-based improvement system with pillars: Measure what matters, Empower Teams, Sustainably Improve, Always Learn
  • Intellectual property and regulatory: Portfolio of patents and trademarks; compliance with ISO standards and FDA requirements integrated into manufacturing and product development
  • Corporate responsibility and human capital: Emphasis on an inclusive workforce, employee engagement, total rewards, health and safety, governance, and data privacy and cybersecurity governance
  • Facilities and properties: Owned facilities in Lakewood (Calibration Solutions) and Bozeman (SDC); multiple leased facilities in Germany, Sweden, and the United States supporting the company’s divisions